Emerging Nanotechnology for Treatment of Alzheimer’s and Parkinson’s Disease

Emerging Nanotechnology for Treatment of Alzheimer’s and Parkinson’s Disease

The prevalence of the two most common neurodegenerative diseases, Parkinson’s disease (PD) and Alzheimer’s Disease (AD), are expected to rise alongside the progressive aging of society. Both PD and AD are classified as proteinopathies with misfolded proteins α-synuclein, amyloid-β, and tau. Emerging...

Full description

Bibliographic Details
Main Authors: Amanda Li, Joel Tyson, Shivni Patel, Meer Patel, Sruthi Katakam, Xiaobo Mao, Weiwei He
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-05-01
Series:Frontiers in Bioengineering and Biotechnology
Subjects:
Parkinson’s disease
Alzheimer’s disease
nanotechnology/nanomaterials
oxidative stress
nanozymes
Online Access:https://www.frontiersin.org/articles/10.3389/fbioe.2021.672594/full

Similar Items

Similar Items